Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test
| Condition(s) | Esophageal Cancer, Gastric Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality? Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors. |
| Who can participate | Inclusion Criteria: 1. Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance) 2. Access to computer or smartphone 3. Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese) Exclusion Criteria: 1. Individuals less than 18yo and more than 75yo 2. Incarcerated individuals |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | KU Leuven |
| Locations | Leuven, Belgium |
| Start date | 2024-08-01 |
| NCT ID | NCT06346080 |
| Official listing | https://clinicaltrials.gov/study/NCT06346080 |